Malignant mesothelioma, a cancer of the mesothelium, often presents as serosal effusion. Diagnosis requires imaging, cytology, and biopsy, with immunohistochemistry aiding confirmation. Survival averages 31.3 months with treatment.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: